Literature DB >> 23868257

Cancer: calculated treatment.

Natalia L Komarova, C Richard Boland.   

Abstract

Entities:  

Year:  2013        PMID： 23868257      PMCID： PMC3831845          DOI： 10.1038/499291a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

Review 1.  Targeting cancer with small molecule kinase inhibitors.

Authors:  Jianming Zhang; Priscilla L Yang; Nathanael S Gray
Journal:  Nat Rev Cancer       Date:  2009-01       Impact factor: 60.716

2.  The worst drug rule revisited: mathematical modeling of cyclic cancer treatments.

Authors:  Allen A Katouli; Natalia L Komarova
Journal:  Bull Math Biol       Date:  2010-04-16       Impact factor: 1.758

3.  Drug resistance in cancer: principles of emergence and prevention.

Authors:  Natalia L Komarova; Dominik Wodarz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-24       Impact factor: 11.205

4.  Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)-based mutagenesis screen: high efficacy of drug combinations.

Authors:  Heather A Bradeen; Christopher A Eide; Thomas O'Hare; Kara J Johnson; Stephanie G Willis; Francis Y Lee; Brian J Druker; Michael W Deininger
Journal:  Blood       Date:  2006-06-13       Impact factor: 22.113

5.  The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers.

Authors:  Luis A Diaz; Richard T Williams; Jian Wu; Isaac Kinde; J Randolph Hecht; Jordan Berlin; Benjamin Allen; Ivana Bozic; Johannes G Reiter; Martin A Nowak; Kenneth W Kinzler; Kelly S Oliner; Bert Vogelstein
Journal:  Nature       Date:  2012-06-28       Impact factor: 49.962

6.  Evolutionary dynamics of cancer in response to targeted combination therapy.

Authors:  Ivana Bozic; Johannes G Reiter; Benjamin Allen; Tibor Antal; Krishnendu Chatterjee; Preya Shah; Yo Sup Moon; Amin Yaqubie; Nicole Kelly; Dung T Le; Evan J Lipson; Paul B Chapman; Luis A Diaz; Bert Vogelstein; Martin A Nowak
Journal:  Elife       Date:  2013-06-25       Impact factor: 8.140

7.  Optimizing combination therapies with existing and future CML drugs.

Authors:  Allen A Katouli; Natalia L Komarova
Journal:  PLoS One       Date:  2010-08-23       Impact factor: 3.240

8.  Combination of two but not three current targeted drugs can improve therapy of chronic myeloid leukemia.

Authors:  Natalia L Komarova; Allen A Katouli; Dominik Wodarz
Journal:  PLoS One       Date:  2009-02-10       Impact factor: 3.240
  8 in total
  25 in total

1.  Body of evidence and approaches applied in the clinical development programme of fixed-dose combinations in the European Union from 2010 to 2016.

Authors:  Asbjørn Nøhr-Nielsen; Marie Louise De Bruin; Mikael Thomsen; Christian Bressen Pipper; Theis Lange; Ole Jannik Bjerrum; Trine Meldgaard Lund
Journal:  Br J Clin Pharmacol       Date:  2019-06-17       Impact factor: 4.335

2.  Combinatorial therapeutic approaches with RNAi and anticancer drugs using nanodrug delivery systems.

Authors:  Anish Babu; Anupama Munshi; Rajagopal Ramesh
Journal:  Drug Dev Ind Pharm       Date:  2017-05-19       Impact factor: 3.225

Review 3.  Combating malaria with nanotechnology-based targeted and combinatorial drug delivery strategies.

Authors:  Miloni Thakkar; Brijesh S
Journal:  Drug Deliv Transl Res       Date:  2016-08       Impact factor: 4.617

4.  Selection of P-Glycoprotein Inhibitor and Formulation of Combinational Nanoformulation Containing Selected Agent Curcumin and DOX for Reversal of Resistance in K562 Cells.

Authors:  Tapan K Dash; V Badireenath Konkimalla
Journal:  Pharm Res       Date:  2017-05-23       Impact factor: 4.200

5.  Effect of aspirin on tumour cell colony formation and evolution.

Authors:  Dominik Wodarz; Ajay Goel; C Richard Boland; Natalia L Komarova
Journal:  J R Soc Interface       Date:  2017-09       Impact factor: 4.118

6.  A System-wide Approach to Monitor Responses to Synergistic BRAF and EGFR Inhibition in Colorectal Cancer Cells.

Authors:  Anna Ressa; Evert Bosdriesz; Joep de Ligt; Sara Mainardi; Gianluca Maddalo; Anirudh Prahallad; Myrthe Jager; Lisanne de la Fonteijne; Martin Fitzpatrick; Stijn Groten; A F Maarten Altelaar; René Bernards; Edwin Cuppen; Lodewyk Wessels; Albert J R Heck
Journal:  Mol Cell Proteomics       Date:  2018-07-03       Impact factor: 5.911

Review 7.  Combination therapies: The next logical Step for the treatment of synucleinopathies?

Authors:  Elvira Valera; Eliezer Masliah
Journal:  Mov Disord       Date:  2015-09-21       Impact factor: 10.338

8.  Synchronous Chemoradiation Nanovesicles by X-Ray Triggered Cascade of Drug Release.

Authors:  Zijian Zhou; Alexander Chan; Zhantong Wang; Xiaolin Huang; Guocan Yu; Orit Jacobson; Sheng Wang; Yijing Liu; Lingling Shan; Yunlu Dai; Zheyu Shen; Lisen Lin; Wei Chen; Xiaoyuan Chen
Journal:  Angew Chem Int Ed Engl       Date:  2018-06-14       Impact factor: 15.336

9.  Andrographis-mediated chemosensitization through activation of ferroptosis and suppression of β-catenin/Wnt-signaling pathways in colorectal cancer.

Authors:  Priyanka Sharma; Tadanobu Shimura; Jasjit K Banwait; Ajay Goel
Journal:  Carcinogenesis       Date:  2020-10-15       Impact factor: 4.944

10.  Tumor Static Concentration Curves in Combination Therapy.

Authors:  Tim Cardilin; Joachim Almquist; Mats Jirstrand; Alexandre Sostelly; Christiane Amendt; Samer El Bawab; Johan Gabrielsson
Journal:  AAPS J       Date:  2016-09-28       Impact factor: 4.009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.